Clinical Trial Update: First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating first-line treatment with the mFOLFOX6/HLX04 regimen followed by Serplulimab in microsatellite-stabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• HLX04 (HLX04)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Serplulimab (serplulimab)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Efficacy, Self, Safety Issues | Phase 2 | Status: NOT_YET_RECRUITING